Schwannoma Mimicking Axillary Lymph Node Metastasis: A Comprehensive Radiology Guide to PET-CT, Ultrasound, MRI, and CT Diagnosis
Schwannoma Mimicking Metastatic Lymphadenopathy:
The Critical Imaging Clues Every Radiologist Must Know
When a cancer patient undergoes PET-CT and an FDG-avid axillary mass is discovered, the immediate concern is usually metastatic lymph node involvement.
In daily radiology practice, increased FDG uptake is often interpreted as evidence of malignancy. However, this assumption can occasionally lead clinicians down the wrong diagnostic path.
A particularly educational case involved a 76-year-old man with a history of nasopharyngeal carcinoma who presented with dysphagia and severe pain. PET-CT revealed an FDG-avid axillary lesion with an SUVmax of approximately 4.5, strongly suggesting metastatic lymphadenopathy.
Yet the final diagnosis was something entirely different:
Schwannoma.
This case highlights one of the most important lessons in modern medical imaging:
FDG uptake does not equal cancer.
Understanding the radiologic features of schwannoma across ultrasound, CT, MRI, and PET-CT is essential for accurate diagnosis, proper biopsy planning, and avoidance of unnecessary interventions.
Clinical Case Overview
Patient Presentation
A 76-year-old male undergoing chemotherapy for nasopharyngeal carcinoma presented with:
Dysphagia
Persistent pain
Incidental PET-positive axillary lesion
The primary concern was metastatic lymph node disease.
Subsequent ultrasound-guided biopsy confirmed:
Benign Schwannoma
This diagnosis dramatically altered management and prognosis.
What Is a Schwannoma?
Schwannoma is a benign tumor arising from Schwann cells, the cells responsible for producing the myelin sheath surrounding peripheral nerves.
It is the most common peripheral nerve sheath tumor and accounts for approximately 89% of benign nerve sheath neoplasms.
Although schwannomas can occur anywhere along peripheral nerves, they most commonly involve:
Head and neck region
Flexor surfaces of extremities
Spinal nerve roots
Brachial plexus
Axillary schwannomas are relatively uncommon and can easily be mistaken for lymph node pathology.
Pathophysiology
Schwannomas originate from monoclonal proliferation of Schwann cells.
Histologically, they contain two characteristic patterns:
Antoni A Areas
Features include:
High cellularity
Spindle-shaped cells
Nuclear palisading
Verocay bodies
Antoni B Areas
Features include:
Hypocellular architecture
Myxoid degeneration
Loose stromal background
Immunohistochemistry
Schwannomas are characteristically:
S-100 positive
SOX10 positive
EMA negative
These markers are critical in differentiating schwannoma from other soft tissue tumors.
Epidemiology
| Parameter | Finding |
|---|---|
| Incidence | Rare |
| Most Common Age | 30–50 years |
| Sex Distribution | Equal |
| Most Common Location | Head and Neck |
| Axillary Location | Approximately 5% |
| Malignant Transformation | Extremely Rare |
Because of their rarity in the axilla, radiologists frequently confuse them with enlarged lymph nodes.
Clinical Presentation
Most schwannomas grow slowly and remain asymptomatic for years.
Common Symptoms
Painless mass
Gradual enlargement
Mild discomfort
Advanced Symptoms
Neuropathic pain
Paresthesia
Sensory disturbances
Muscle weakness
Nerve compression symptoms
An important clue is pain provoked during needle biopsy.
In the presented case, severe pain occurred during ultrasound-guided biopsy despite local anesthesia, suggesting a neural origin.
Figure 1. FDG-avid right axillary mass on PET/CT
Radiologic Interpretation
PET/CT demonstrates a solitary hypermetabolic lesion in the right axilla with SUVmax approximately 4.5.
Diagnostic Significance
Important observations:
Moderate FDG uptake
Well-circumscribed lesion
No obvious aggressive invasion
Key Teaching Point
Benign schwannomas frequently exhibit FDG uptake.
Therefore:
FDG positivity alone cannot distinguish benign from malignant lesions.
Many radiologists and oncologists incorrectly assume that PET-positive lesions in cancer patients automatically represent metastases.
This case proves otherwise.
Imaging Features of Schwannoma
Ultrasound Findings
Ultrasound is often the first imaging modality.
Typical features include:
Well-defined margins
Homogeneous hypoechogenicity
Oval shape
Posterior acoustic enhancement
Minimal vascularity
Figure 2. Well-circumscribed hypoechoic axillary mass adjacent to neurovascular structures
Radiologic Interpretation
Ultrasound reveals a 2.0 × 1.5 × 1.5 cm hypoechoic mass located adjacent to the axillary vessels.
Diagnostic Clues
Smooth margins
Homogeneous echotexture
Lack of hilar architecture
Minimal Doppler flow
Clinical Relevance
Biopsy carries a significant risk of:
Nerve injury
Persistent neuralgia
Severe procedural pain
Recognition before biopsy is extremely important.
Figure 3. Sonographic features favoring a peripheral nerve sheath tumor rather than a lymph node
Radiologic Interpretation
The lesion lacks typical lymph node morphology.
Key Findings
Absence of fatty hilum
No cortical thickening pattern
Suspicious continuity with the adjacent nerve
Diagnostic Contribution
These findings strongly favor schwannoma over metastatic lymphadenopathy.
CT Imaging Findings
Figure 4. Chest CT
Findings
1. Location and Morphology of the Lesion
Location: A solitary nodular lesion is observed in the right anterior axillary region and the subpectoral space. (Indicated by the red arrow)
Morphology: The lesion is well-circumscribed with relatively distinct borders and presents a round to oval shape.
2. Attenuation Characteristics
It exhibits an overall low to intermediate soft-tissue attenuation compared to the surrounding muscle tissue.
Due to its tomographic features, the lesion highly mimics lymphadenopathy. Visually, it can easily be misidentified as axillary lymph node metastasis from breast cancer or other malignant tumors.
Conclusion: Schwannoma in the right axillary region
Differential Diagnosis: As suggested by the clinical title ("Schwannoma Mimicking Axillary Lymph Node Metastasis"), this lesion can easily be suspected as malignant lymph node metastasis due to its location and morphology, but it is actually a case diagnosed as a schwannoma.
Characteristics: This is a benign tumor originating from the peripheral nerve sheath, most likely arising from the brachial plexus or its branches in the axillary region. An MRI scan or a biopsy is typically required for an accurate differential diagnosis from malignant metastatic diseases.
Typical CT Characteristics
Well-defined soft tissue mass
Strong enhancement after contrast
Eccentric relationship to the parent nerve
Rare calcification
Ancient Schwannoma
May demonstrate:
Cystic degeneration
Hemorrhage
Calcification
These findings can occasionally mimic malignancy.
MRI Findings: The Gold Standard
MRI provides the highest diagnostic accuracy.
Figure 5. MRI
Findings
1. Lesion Location and Morphology
Location: A solitary nodular lesion is identified in the right subpectoral/anterior axillary space (indicated by the red arrows), closely adjacent to the neurovascular bundle.
Morphology: The mass is well-circumscribed, with a well-defined round-to-oval configuration and smooth margins.
2. Signal Intensity Characteristics
T1-weighted Image (A): The lesion exhibits homogeneous low-to-intermediate signal intensity, showing a clear demarcation from the adjacent muscle and surrounding fat tissue.
T2-weighted / Fat-suppressed Image (B): The lesion demonstrates prominent, diffuse high signal intensity. It shows a slightly heterogeneous internal architecture with a hyperintense periphery, which is highly characteristic of a neurogenic tumor.
Conclusion / Impression
Schwannoma in the right axillary region (mimicking axillary lymph node metastasis)
Key Diagnostic Features: While the anatomical location and nodular shape on routine screening can be easily misidentified as an isolated axillary lymph node metastasis (e.g., from breast cancer), the characteristic MRI features—specifically the well-defined borders and bright T2 hyperintensity—strongly support a benign peripheral nerve sheath tumor (schwannoma) arising from the brachial plexus or its branches.
Target Sign
A classic sign consisting of:
Central low signal
Peripheral high signal
on T2-weighted images.
Fascicular Sign
Appearance resembling nerve fascicles.
Split Fat Sign
Peripheral rim of surrounding fat.
These findings strongly support benign peripheral nerve sheath tumors.
Differential Diagnosis
Correct differential diagnosis is crucial.
1. Metastatic Lymph Node
Most important consideration.
Particularly in patients with:
Breast cancer
Lung cancer
Nasopharyngeal carcinoma
Differentiating Features
| Feature | Schwannoma | Metastatic Node |
|---|---|---|
| Fatty Hilum | Absent | Usually Absent |
| Neural Continuity | Present | Absent |
| Biopsy Pain | Common | Rare |
| Target Sign | Present | Absent |
2. Neurofibroma
It can closely resemble a schwannoma.
Neurofibromas tend to:
Involve the nerve centrally
Be multiple
Associate with Neurofibromatosis Type 1
3. Reactive Lymph Node
Usually shows:
Preserved fatty hilum
Normal hilar vascularity
Stable morphology
4. Necrotic Lymph Node
Features include:
Central necrosis
Irregular enhancement
Aggressive appearance
Diagnostic Workflow
Step 1
Clinical history
Ask:
Cancer history?
Neuropathic symptoms?
Growth rate?
Step 2
Ultrasound
Evaluate:
Fatty hilum
Neural continuity
Doppler flow
Step 3
Contrast-enhanced CT
Assess:
Enhancement pattern
Relationship to vessels
Nerve origin
Step 4
MRI
Look for:
Target sign
Fascicular sign
Split fat sign
Step 5
Histopathology
Definitive diagnosis:
Verocay bodies
Antoni A/B areas
S100 positivity
Treatment
Management depends on symptoms.
Observation
Suitable for:
Small lesions
Asymptomatic patients
Elderly patients
Surgical Excision
Current gold standard.
Advantages:
Curative
Low recurrence rate
Excellent symptom relief
Surgery is particularly recommended when:
Pain exists
Neurologic symptoms occur
Tumor growth is documented
Prognosis
Schwannoma generally carries an excellent prognosis.
Outcomes
Rare recurrence after complete excision
Extremely rare malignant transformation
Excellent long-term survival
Most patients achieve complete symptom resolution.
Key Radiology Pearls
Radiologists should remember:
✓ PET-positive does not mean malignant
✓ Severe pain during biopsy suggests nerve origin
✓ Lack of a fatty hilum argues against a lymph node
✓ MRI Target Sign strongly supports schwannoma
✓ CT evaluation of neurovascular relationships is critical
✓ Always consider schwannoma in FDG-avid axillary masses
Clinical Scenario
Imagine reviewing a PET-CT from a cancer patient.
A hypermetabolic axillary lesion appears.
The temptation is immediate:
"Metastatic lymph node."
However, one additional ultrasound image reveals:
No fatty hilum
Neural continuity
Marked pain during biopsy
Suddenly, the diagnosis changes entirely.
This is precisely why multimodality medical imaging remains indispensable in modern radiology interpretation.
Key Takeaways
Schwannoma is the most common benign peripheral nerve sheath tumor.
PET positivity does not imply malignancy.
Ultrasound provides important clues regarding neural origin.
MRI remains the most accurate diagnostic modality.
CT is crucial for anatomical localization and surgical planning.
Accurate radiology interpretation prevents misdiagnosis and unnecessary treatment.
Educational Quiz
Question 1
A 68-year-old man presents with an axillary mass. MRI demonstrates a Target Sign. What is the most likely diagnosis?
A. Metastatic lymph node
B. Schwannoma
C. Lipoma
D. Abscess
E. Hemangioma
Correct Answer
B. Schwannoma
Explanation
The Target Sign is a classic MRI finding of benign peripheral nerve sheath tumors, particularly schwannoma.
Question 2
Which histologic feature is most characteristic of schwannoma?
A. Reed-Sternberg cell
B. Psammoma body
C. Verocay body
D. Keratin pearl
E. Signet-ring cell
Correct Answer
C. Verocay body
Explanation
Verocay bodies arise within Antoni A regions and represent one of the hallmark histologic features of schwannoma.
Question 3
Which statement regarding schwannoma is correct?
A. FDG uptake never occurs
B. Always malignant
C. S100 negative
D. Frequently recurs after surgery
E. S100 positive
Correct Answer
E. S100 positive
Explanation
Schwannomas arise from Schwann cells and show strong S100 positivity on immunohistochemistry.
Frequently Asked Questions (FAQ)
Can a schwannoma appear malignant on PET-CT?
Yes. Schwannomas often demonstrate significant FDG uptake and may mimic metastatic disease.
Is MRI better than CT for schwannoma?
Yes. MRI provides superior soft tissue characterization and shows classic findings such as the Target Sign.
Are schwannomas cancerous?
Most are benign. Malignant transformation is exceedingly rare.
Is surgery always necessary?
No. Small asymptomatic lesions can often be monitored.
Why is a biopsy painful?
Because the lesion originates from nerve tissue, needle manipulation may stimulate sensory fibers and cause intense pain.
Recommended Reading
F. D. Beaman et al., “Schwannoma: Radiologic-Pathologic Correlation,” RadioGraphics, vol. 24, no. 5, pp. 1477–1481, 2004. DOI: https://doi.org/10.1148/rg.245045001
S. Beaulieu et al., “FDG PET of Schwannomas,” American Journal of Roentgenology, vol. 182, pp. 971–976, 2004. DOI: https://doi.org/10.2214/ajr.182.4.1820971
P. Albert et al., “Peripheral Nerve Schwannoma,” Journal of Foot and Ankle Surgery, 2017. DOI: https://doi.org/10.1053/j.jfas.2016.11.008
H. Aref and G. A. Abizeid, “Axillary Schwannoma,” International Journal of Surgery Case Reports, 2018. DOI: https://doi.org/10.1016/j.ijscr.2018.09.017
N. U. Din et al., “Calcification and Ossification in Conventional Schwannoma,” Neuropathology, 2020. DOI: https://doi.org/10.1111/neup.12627
M. Duehrkoop et al., “Axillary Schwannoma Imitating Nodal Metastasis,” Radiology Case Reports, 2021. DOI: https://doi.org/10.1016/j.radcr.2021.05.051
M. M. Sheikh and O. De Jesus, “Schwannoma,” StatPearls, 2022. DOI: https://www.ncbi.nlm.nih.gov/books/NBK562312/
J. M. Knight et al., “Benign Peripheral Nerve Sheath Tumors: Imaging Features,” AJR American Journal of Roentgenology, 2023.
Comments
Post a Comment